Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Return on Assets: 2021-2025

Historic Return on Assets for Burning Rock Biotech (BNR) over the last 4 years, with Mar 2025 value amounting to 0.13%.

  • Burning Rock Biotech's Return on Assets rose 33.00% to 0.13% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.13%, marking a year-over-year increase of 33.00%. This contributed to the annual value of -0.34% for FY2024, which is 14.00% up from last year.
  • According to the latest figures from Q1 2025, Burning Rock Biotech's Return on Assets is 0.13%, which was up 136.38% from -0.35% recorded in Q4 2024.
  • In the past 5 years, Burning Rock Biotech's Return on Assets registered a high of 2.56% during Q3 2024, and its lowest value of -0.48% during Q2 2022.
  • Moreover, its 3-year median value for Return on Assets was 0.13% (2025), whereas its average is 0.33%.
  • Over the last 5 years, Burning Rock Biotech's Return on Assets had its largest YoY gain of 233bps in 2024, and its largest YoY loss of 59bps in 2024.
  • Burning Rock Biotech's Return on Assets (Quarterly) stood at -0.34% in 2021, then soared by 65bps to 0.31% in 2022, then declined by 21bps to 0.10% in 2023, then plummeted by 45bps to -0.35% in 2024, then soared by 33bps to 0.13% in 2025.
  • Its Return on Assets stands at 0.13% for Q1 2025, versus -0.35% for Q4 2024 and 2.56% for Q3 2024.